Publications by authors named "Benjamin Billingsley"
Article Synopsis
- - The study highlights that quick initiation of biologic therapy is crucial for patients with inflammatory bowel disease (IBD), but various factors can delay this process in an outpatient setting.
- - Researchers analyzed data from 411 patients receiving biologics between March 2019 and September 2020, finding an overall median delay of 20 days, with specific delays varying by medication.
- - Key factors contributing to delays included being self-identified as Black, living farther from treatment facilities, and not having immediate insurance coverage approval.
An inflammatory myofibroblastic tumor (IMT) is a rare mesenchymal neoplasm of borderline malignant potential. Nearly half of all IMTs have rearrangement of anaplastic lymphoma kinase (ALK) locus on chromosome 2p23 which can be treated with targeted therapy. Herein, we describe an unusual presentation of IMT involving an anatomical region rarely implicated in this disease process.
View Article and Find Full Text PDFBackground And Objectives: While the relationship between recreational cannabis and nicotine use is well established, little is known about nicotine use among users of cannabis for therapeutic purposes (CTP).
Methods: Patients attending a medical marijuana dispensary (N = 697; 75.3% White; 60.
Change talk, or client language that is consistent with making a behavioral change, has been found to improve the efficacy of motivational interviewing (MI). It is not known, however, if change talk helps to explain MI's effect on instigating a quit attempt in smokers with serious mental illness. We measured change talk in smokers with a serious mental illness (SMI) randomized to receive either a single session adaptation of motivational interviewing or an interactive education intervention.
View Article and Find Full Text PDFGiven that impulse control disorders (ICDs) have been identified among a considerable minority of Parkinson's disease (PD) patients, these conditions have gained increased clinical and research attention in the past decade. Dopamine-replacement therapies, taken to ameliorate PD symptoms, have been associated with ICDs in PD. Unfortunately, there are relatively sparse empirical data regarding how best to address ICDs in PD patients.
View Article and Find Full Text PDF